We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current KRYS market cap is 4.26B. The company's latest EPS is USD 3.0852 and P/E is 47.87.
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 45.25M | 70.29M | 83.84M | 91.14M | 88.18M |
| Operating Income | -6.68M | 8.57M | 22.43M | 41.38M | 36.18M |
| Net Income | 932k | 15.57M | 27.18M | 45.48M | 35.73M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 50.7M | 290.52M |
| Operating Income | -33M | -68.28M | -145.2M | -109.73M | 65.7M |
| Net Income | -32.17M | -69.57M | -139.98M | 10.93M | 89.16M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 853.3M | 917.66M | 982.32M | 1.06B | 1.07B |
| Total Liabilities | 54.05M | 78.77M | 96.47M | 109.46M | 89.74M |
| Total Equity | 799.24M | 838.89M | 885.85M | 946.38M | 984.67M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 310.84M | 626.3M | 558.45M | 818.36M | 1.06B |
| Total Liabilities | 18.76M | 32.72M | 36.22M | 39.71M | 109.46M |
| Total Equity | 292.08M | 593.58M | 522.23M | 778.64M | 946.38M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 15.89M | 11.72M | 70.58M | 123.42M | 30.97M |
| Investing | -25.98M | -45.33M | -79.66M | -163.44M | -54.77M |
| Financing | 10.58M | 21.22M | 24.59M | 27.01M | -12.47M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -26.08M | -47.94M | -100.57M | -88.8M | 123.42M |
| Investing | -11.18M | -226.77M | -114.08M | 82.64M | -163.44M |
| Financing | 118.02M | 347.69M | 35.35M | 202.75M | 27.01M |
| Market Cap | 4.26B |
| Price to Earnings Ratio | 47.87 |
| Price to Sales Ratio | 14.69 |
| Price to Cash Ratio | 12.38 |
| Price to Book Ratio | 4.51 |
| Dividend Yield | - |
| Shares Outstanding | 28.9M |
| Average Volume (1 week) | 281.59k |
| Average Volume (1 Month) | 366.88k |
| 52 Week Change | -28.93% |
| 52 Week High | 219.34 |
| 52 Week Low | 122.80 |
| Spread (Intraday) | 29.5 (19.41%) |
| Company Name | Krystal Biotech Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.krystalbio.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
